It is plausible that at appropriately high concentrations, melatonin modulates the inhospitable, highly stressful tumor microenvironment (TME) to attenuate elevated PrPC stress responses that may activate the conversion into pathological, self-templating aggregates, whereas lower levels support the natural, physiological protective reactions of prions under duress. This evidence concerns the gene PRNP and neoplasm.